Literature DB >> 17376125

Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.

J S Kalkman1, M L Schillings, M J Zwarts, B G M van Engelen, G Bleijenberg.   

Abstract

OBJECTIVES: To study the presence of psychiatric comorbidity assessed by the use of a structured clinical interview and self-reported questionnaires in a large sample of patients with adult-onset myotonic dystrophy (DM), facioscapulohumeral muscular dystrophy (FSHD), and hereditary motor and sensory neuropathy type I (HMSN-I), and to assess whether psychiatric comorbidity is related to fatigue severity and/or muscle strength.
METHODS: In a cohort of 217 patients with a neuromuscular disorder (79 DM, 65 FSHD and 73 HMSN-I patients) overall psychiatric comorbidity was studied cross-sectionally with the structured clinical interview for DSM-IV axis I disorders. Self-reported psychopathology, fatigue severity and muscle strength were assessed with the Beck Depression Inventory, Symptom Checklist-90, General Health Questionnaire-12, Checklist Individual Strength and muscle strength [Medical Research Council (MRC)-scale].
RESULTS: In all three neuromuscular disorders (DM, FSHD and HMSN), 10-12% of the patients met DSM IV clinical criteria for current psychiatric disorders. Lifetime psychiatric disorders were found in 32% of patients in all three patient groups. The most common psychiatric disorders were depression and phobias. A comparison of patients with and without current psychiatric disorder showed that fatigue severity and muscle strength (MRC) were not related to psychiatric comorbidity.
CONCLUSION: Psychiatric disorders appear equally in patients with DM, FSHD and HMSN-I and are not related to fatigue or muscle strength in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17376125     DOI: 10.1111/j.1600-0404.2006.00737.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

1.  If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  James E Hilbert; John T Kissel; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Donald B Sanders; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Contemp Clin Trials       Date:  2011-11-26       Impact factor: 2.226

2.  Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates.

Authors:  Stefan Winblad; Christer Jensen; Jan-Eric Månsson; Lena Samuelsson; Christopher Lindberg
Journal:  Behav Brain Funct       Date:  2010-05-19       Impact factor: 3.759

3.  Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.

Authors:  Joke S Kalkman; Machiel J Zwarts; Maartje L Schillings; Baziel G M van Engelen; Gijs Bleijenberg
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

4.  Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers.

Authors:  Patricia Arashiro; Iris Eisenberg; Alvin T Kho; Antonia M P Cerqueira; Marta Canovas; Helga C A Silva; Rita C M Pavanello; Sergio Verjovski-Almeida; Louis M Kunkel; Mayana Zatz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-01       Impact factor: 11.205

5.  Risk of fracture in patients with muscular dystrophies.

Authors:  S Pouwels; A de Boer; H G M Leufkens; W E J Weber; C Cooper; H A W van Onzenoort; F de Vries
Journal:  Osteoporos Int       Date:  2013-08-15       Impact factor: 4.507

Review 6.  Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review.

Authors:  Joana L C Cordeiro; Wilson Marques; Jaime E C Hallak; Flávia L Osório
Journal:  ASN Neuro       Date:  2014-05-27       Impact factor: 4.146

Review 7.  A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.

Authors:  Lisa Minier; Baptiste Lignier; Cyrille Bouvet; Benjamin Gallais; Nathalie Camart
Journal:  J Neuromuscul Dis       Date:  2018

8.  Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

Authors:  Jacob N Miller; Alison Kruger; David J Moser; Laurie Gutmann; Ellen van der Plas; Timothy R Koscik; Sarah A Cumming; Darren G Monckton; Peggy C Nopoulos
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

9.  Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism.

Authors:  Zuzana Musova; Miroslava Hancarova; Marketa Havlovicova; Radka Pourova; Michal Hrdlicka; Josef Kraus; Marie Trkova; David Stejskal; Zdenek Sedlacek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-19       Impact factor: 2.570

10.  Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Authors:  Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola
Journal:  Front Neurol       Date:  2018-09-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.